Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
04 11 2021
Historique:
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 6 4 2022
Statut: epublish

Résumé

Myocardial infarction (MI) is the leading cause of mortality worldwide. Despite the use of evidence-based treatments, including coronary revascularization and cardiovascular drugs, a significant proportion of patients develop pathological left-ventricular remodeling and progressive heart failure following MI. Therefore, new therapeutic options, such as cellular and gene therapies, among others, have been developed to repair and regenerate injured myocardium. In this context, animal models of MI are crucial in exploring the safety and efficacy of these experimental therapies before clinical translation. Large animal models such as swine are preferred over smaller ones due to the high similarity of swine and human hearts in terms of coronary artery anatomy, cardiac kinetics, and the post-MI healing process. Here, we aimed to describe an MI model in pig by permanent coil deployment. Briefly, it comprises a percutaneous selective coronary artery cannulation through retrograde femoral access. Following coronary angiography, the coil is deployed at the target branch under fluoroscopic guidance. Finally, complete occlusion is confirmed by repeated coronary angiography. This approach is feasible, highly reproducible, and emulates the pathogenesis of human non-revascularized MI, avoiding the traditional open-chest surgery and the subsequent postoperative inflammation. Depending on the time of follow-up, the technique is suitable for acute, sub-acute, or chronic MI models.

Identifiants

pubmed: 34806712
doi: 10.3791/63172
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Auteurs

Daina Martínez-Falguera (D)

ICREC Research Program, Germans Trias i Pujol Health Research Institute (IGTP); Faculty of Medicine, University of Barcelona (UB).

Edgar Fadeuilhe (E)

Heart Institute (iCOR), Germans Trias i Pujol University Hospital.

Albert Teis (A)

Heart Institute (iCOR), Germans Trias i Pujol University Hospital.

Julia Aranyo (J)

Heart Institute (iCOR), Germans Trias i Pujol University Hospital.

Raquel Adeliño (R)

ICREC Research Program, Germans Trias i Pujol Health Research Institute (IGTP); Heart Institute (iCOR), Germans Trias i Pujol University Hospital.

Felipe Bisbal (F)

Heart Institute (iCOR), Germans Trias i Pujol University Hospital; CIBER Cardiovascular, Instituto de Salud Carlos III.

Oriol Rodriguez-Leor (O)

Heart Institute (iCOR), Germans Trias i Pujol University Hospital; CIBER Cardiovascular, Instituto de Salud Carlos III.

Carolina Gálvez-Montón (C)

ICREC Research Program, Germans Trias i Pujol Health Research Institute (IGTP); Heart Institute (iCOR), Germans Trias i Pujol University Hospital; CIBER Cardiovascular, Instituto de Salud Carlos III; cgalvez@igtp.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH